Meropenem Cf

Meropenem, the active ingredient in Meropenem Cf, is a carbapenem presented as a sterile powder for reconstitution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired pneumonia, and septicemia in hospitalized adult patients.

GNH USA supplies Meropenem Cf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, providing consistent product quality and regulatory compliance for global healthcare needs and supporting antimicrobial stewardship programs.

Meropenem is a broad‑spectrum carbapenem antibiotic used to treat serious bacterial infections.

Complicated intra‑abdominal infections: achieves clinical cure and microbiological eradication. Complicated urinary tract infections: provides effective bacterial clearance. Hospital‑acquired pneumonia: resolves infection caused by resistant Gram‑negative pathogens. Septicemia: rapidly reduces bacterial load in bloodstream infections. Complicated skin and soft‑tissue infections: offers coverage when other agents are unsuitable. Febrile neutropenia: supplies broad coverage against resistant organisms.

Adverse reactions may occur with meropenem therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Headache: transient cranial discomfort. - Rash: mild skin erythema or pruritus.

Serious or Rare Side Effects: - Seizures: increased risk in patients with CNS disorders or renal impairment. - Clostridioides difficile infection: severe colitis may develop. - Anaphylaxis: acute hypersensitivity requiring immediate medical attention.

Careful assessment and monitoring are required when using meropenem.

Renal function: adjust dose in patients with impaired renal function. Allergy: avoid in individuals with known hypersensitivity to carbapenems or β‑lactams. Seizure risk: monitor closely in patients with a history of seizures or CNS disorders. Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. Drug interactions: review concomitant medications for possible interactions. Store at 2‑8°C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with several concomitant drugs.

Major Interactions (Avoid): - Valproic acid: reduces serum levels, increasing seizure risk. - CNS stimulants (e.g., tramadol): may lower seizure threshold. - Nephrotoxic agents (e.g., high‑dose aminoglycosides): can exacerbate renal injury.

Moderate Interactions (Monitor Closely): - Loop diuretics: may affect renal clearance of meropenem. - Aminoglycosides: additive nephrotoxicity requires renal function monitoring. - Oral contraceptives: possible reduction in efficacy, advise alternative contraception.